Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya
Harambee:基于社区的艾滋病毒/非传染性疾病综合护理
基本信息
- 批准号:10608126
- 负责人:
- 金额:$ 50.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-05 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAfrica South of the SaharaBiometryCaringCommunitiesContinuity of Patient CareControl GroupsCost AnalysisDataDiseaseDrug resistanceEconomic ConditionsEconomicsEffectivenessEnsureExposure toFamilyFoodFriendsFutureGoalsHIVHealthHealth Services AccessibilityHealthcareHouseholdIncomeIndividualInterventionKenyaLow incomeMediatingMediationMethodsModelingMorbidity - disease rateOutcomePathway interactionsPatient-Focused OutcomesPatientsPersonsPoliciesPrevalencePreventionPrimary CareProliferatingQualitative MethodsRandomizedResourcesRuralService delivery modelServicesSiteSocial supportTestingTimeTreatment outcomeUninsuredUnited States National Institutes of HealthViralacceptability and feasibilityantiretroviral therapybarrier to carecare deliverycommunity based carecostcost effectivecost effectivenessdisability-adjusted life yearseffectiveness measureepidemic responseexperiencefood securityhealth care availabilityhealth economicsimplementation contextimplementation interventionimplementation researchimprovedinnovationintegrated caremortalitymultidisciplinarypatient retentionprogramsresistant strainrural settingsocial epidemiologysocial stigmastandard caresystem-level barrierstherapy adherencetherapy designtransmission process
项目摘要
PROJECT SUMMARY/ABSTRACT
Sustained viral suppression (VS) continues to present major challenges to HIV treatment and prevention.
Retention in care is a particularly challenging issue for persons living with HIV (PLHIV) because of lack of
convenient access and issues related to economic stability. Our long-term goal is to help achieve the 90-90-90
goals through improved care delivery based on rigorous implementation research. The objective of this project
is to demonstrate the effectiveness and longer-term sustainability of a differentiated care delivery model for
improving HIV treatment outcomes. The central hypothesis is that the integration of HIV care delivery and
community-based primary care with group-based microfinance will improve retention and rates of VS among
PLHIV in Kenya via two mechanisms: improved household economic status and easier access to care. Thus,
the specific aims are as follows: (1) To evaluate the extent to which integrated community-based HIV care with
group microfinance affects retention in care and VS among PLHIV in rural western Kenya using a cluster
randomized intervention design of existing (fully HIV+) microfinance groups to receive either: (A) integrated
community-based HIV care, or (B) standard care. We will also augment trial data with a matched
contemporaneous control group of patients in standard care (group C) comparing outcomes in groups A, B and
C; (2) To identify specific mechanisms through which microfinance and integrated community-based care impact
VS: Using a mixed methods approach, we will characterize the mechanisms of effect on patient outcomes. We
will conduct quantitative mediation analysis to examine two main mediating pathways (household economic
conditions and easier access to care), as well as exploratory mechanisms (food security, social support, HIV-
related stigma). We will also use qualitative methods and multi-stakeholder panels to contextualize the
implementation of the intervention; and (3) To assess the cost-effectiveness of microfinance and integrated
community-based care delivery to maximize future policy and practice relevance of this promising intervention
strategy. Our working hypothesis is that the differentiated model will be cost-effective in terms of cost per HIV
suppressed person-time, cost per patient retained in care, and cost per disability-adjusted life year saved. This
project is part of the Academic Model Providing Access to Healthcare (AMPATH) program in western Kenya
which cares for more than 150,000 PLHIV at over 500 sites in western Kenya since 2001. The main expected
outcomes will be rigorous evidence of effectiveness, mechanisms and cost-effectiveness of a differentiated
model for achieving the last key step in the HIV care continuum. These results are expected to have an important
positive impact in terms of improved, high-quality services that address known individual and structural barriers
to care and promote long-term sustainability of care for PLHIV in rural settings with high HIV prevalence.
项目摘要/摘要
持续的病毒抑制继续给艾滋病毒的治疗和预防带来重大挑战。
对艾滋病毒携带者(PLHIV)来说,留住护理是一个特别具有挑战性的问题,因为缺乏
便利的交通和与经济稳定有关的问题。我们的长期目标是帮助实现90-90-90
在严格执行研究的基础上,通过改进护理提供来实现目标。这个项目的目标是
是为了展示差异化护理提供模式的有效性和长期可持续性
改善艾滋病毒治疗结果。中心假设是艾滋病毒护理服务和服务的整合
以社区为基础的初级保健和以团体为基础的小额信贷将提高保留率和VS率
通过两种机制在肯尼亚传播艾滋病毒:改善家庭经济状况和更容易获得护理。因此,
具体目标如下:(1)评估以社区为基础的艾滋病毒综合护理与
集团小额信贷影响肯尼亚西部农村地区艾滋病毒感染者的护理保留率和VS
现有(完全艾滋病毒+)小额信贷群体的随机干预设计,接受以下两种方案之一:(A)综合
以社区为基础的艾滋病毒护理,或(B)标准护理。我们还将使用匹配的
同时接受标准护理的患者对照组(C组)比较A、B和
C;(2)确定小额供资和以社区为基础的综合护理产生影响的具体机制
VS:使用混合方法,我们将描述影响患者预后的机制。我们
将进行量化中介分析,以考察两条主要的中介途径(家庭经济
条件和更容易获得护理),以及探索性机制(粮食安全、社会支持、艾滋病毒--
相关污名)。我们还将使用定性方法和多方利益攸关方小组来确定
实施干预措施;以及(3)评估小额供资和综合供资的成本效益
以社区为基础的护理提供,以最大限度地提高这一前景看好的干预措施的未来政策和实践相关性
策略。我们的工作假设是,就每艾滋病毒的成本而言,差异化模型将是具有成本效益的
被抑制的人-时间、保留在护理中的每个患者的成本,以及每个残疾调整后的生命年节省的成本。这
该项目是肯尼亚西部提供医疗服务的学术模式(AMPATH)计划的一部分
自2001年以来,该组织在肯尼亚西部的500多个地点照顾了150,000多名艾滋病病毒感染者。主要预期
结果将是差异化的有效性、机制和成本效益的严格证据
实现艾滋病毒护理连续体最后关键一步的典范。这些结果预计将产生重要的
在改善高质量服务方面产生积极影响,以解决已知的个人和结构性障碍
在艾滋病毒感染率较高的农村地区,护理和促进艾滋病的长期可持续性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interruptions to HIV Care Delivery During Pandemics and Natural Disasters: A Qualitative Study of Challenges and Opportunities From Frontline Healthcare Providers in Western Kenya.
大流行和自然灾害期间艾滋病毒护理提供的中断:肯尼亚西部一线医疗保健提供者的挑战和机遇的定性研究。
- DOI:10.1177/23259582231152041
- 发表时间:2023-01
- 期刊:
- 影响因子:0
- 作者:Tran, Dan N.;Ching, Jennifer;Kafu, Catherine;Wachira, Juddy;Koros, Hillary;Venkataramani, Maya;Said, Jamil;Pastakia, Sonak D.;Galarraga, Omar;Genberg, Becky L.
- 通讯作者:Genberg, Becky L.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Omar Galarraga其他文献
Omar Galarraga的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Omar Galarraga', 18)}}的其他基金
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial
对广泛使用的基于保险的锻炼货币激励计划的实证检验:一项随机试验
- 批准号:
10278186 - 财政年份:2021
- 资助金额:
$ 50.68万 - 项目类别:
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial
对广泛使用的基于保险的锻炼货币激励计划的实证检验:一项随机试验
- 批准号:
10668257 - 财政年份:2021
- 资助金额:
$ 50.68万 - 项目类别:
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial
对广泛使用的基于保险的锻炼货币激励计划的实证检验:一项随机试验
- 批准号:
10450888 - 财政年份:2021
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10347692 - 财政年份:2021
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10334016 - 财政年份:2020
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10219932 - 财政年份:2020
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10620772 - 财政年份:2020
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10427261 - 财政年份:2020
- 资助金额:
$ 50.68万 - 项目类别:
Impact of Prescription Caps on Health Outcomes in People Infected with HIV
处方上限对艾滋病毒感染者健康结果的影响
- 批准号:
10075466 - 财政年份:2020
- 资助金额:
$ 50.68万 - 项目类别:
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya
Harambee:基于社区的艾滋病毒/非传染性疾病综合护理
- 批准号:
10388112 - 财政年份:2019
- 资助金额:
$ 50.68万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 50.68万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 50.68万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 50.68万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 50.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




